GENE ONLINE|News &
Opinion
Blog

Asia-Pacific
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
China’s Biocytogen And FineImmune Bring TCR-Mimic Antibodies And Cell Therapy Together
2022-09-16
Japan Approves AstraZeneca’s Complement Inhibitor For Rare Muscle Disorder
2022-08-26
BIOPLUS-INTERPHEX Korea 2022: The Now and Tomorrow of Korea’s Biotechnology Industry
2022-08-15
CK Life Sciences and CK Hutchison Invest in Taiwanese Liquid Biopsy Candidate
2022-07-26
Takeda Reveals Positive Data on Takhzyro at EAACI
2022-07-01
ASEAN Health Officials to Establish Regional CDC Following COVID-19
2022-05-18
P&G Health dons the Purple Ribbon to commemorate Neuropathy Awareness Week
2022-05-17
LOTTE Corporation Buys Bristol Myers Squibb’s New York Manufacturing Plant for $160 Million
2022-05-16
Bora Pharmaceuticals Expands with Eden Biologics’ CDMO Purchase
2022-05-11
APAC-Focused Novotech Buys US CRO and Expands Global Footprint
2022-05-06
Spying Rapid Growth, Avantor Invests in Manufacturing Hub in Singapore
2022-05-05
APCM 2022: Precision Medicine Is Opening Up a New Prospect of Cancer Therapy
2022-05-04Partner
Novo Nordisk’s Type 2 Diabetes Drug Gets Greenlight in Korea
2022-05-04
1 2 3 28
LATEST
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!